Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
92.92 CHF | -0.16% | +3.48% | +9.46% |
May. 13 | Legend Biotech 1Q Loss Narrows with Higher Carvykti Sales | DJ |
May. 10 | Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.46% | 209B | |
+29.98% | 682B | |
+32.63% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.75% | 240B | |
-8.88% | 203B | |
+7.09% | 165B | |
-1.22% | 161B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis Strengthens Renal Portfolio With $3.5 Billion Takeover of Rare Disease-focused Chinook Therapeutics